港股创新药板块午后持续走强，诺诚健华涨超10%

Group 1 - The Hong Kong innovative drug sector showed strong performance in the afternoon, with notable increases in stock prices for companies such as Innovent Biologics and I-Mab, both rising over 10% [1] - BeiGene's stock also experienced a significant increase, nearing 10%, alongside substantial gains for CSPC Pharmaceutical Group, Rongchang Biopharmaceutical, and WuXi Biologics [1] - The article highlights that investors can buy Hong Kong stocks through A-share accounts without the need for the Hong Kong Stock Connect, allowing for T+0 trading [1]